348 related articles for article (PubMed ID: 34151546)
21. Prognostic value of serum hyponatremia for outcomes in patients with heart failure with preserved ejection fraction: An observational cohort study.
Su Y; Ma M; Zhang H; Pan X; Zhang X; Zhang F; Lv Y; Yan C
Exp Ther Med; 2020 Nov; 20(5):101. PubMed ID: 32973950
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
[TBL] [Abstract][Full Text] [Related]
23. Long-term Prognostic Significance of Admission Tricuspid Regurgitation Pressure Gradient in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction: A Report From the Japanese Real-World Multicenter Registry.
Omote K; Nagai T; Kamiya K; Aikawa T; Tsujinaga S; Kato Y; Komoriyama H; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
J Card Fail; 2019 Dec; 25(12):978-985. PubMed ID: 31344403
[TBL] [Abstract][Full Text] [Related]
24. Mean platelet volume: a prognostic marker in heart failure with preserved ejection fraction.
Menghoum N; Beauloye C; Lejeune S; Badii MC; Gruson D; van Dievoet MA; Pasquet A; Vancraeynest D; Gerber B; Bertrand L; Horman S; Pouleur AC
Platelets; 2023 Dec; 34(1):2188965. PubMed ID: 37157842
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of NT-proBNP, and echocardiographic indices of diastolic function, in hospitalized patients with acute heart failure and preserved left ventricular ejection fraction.
Blanco R; Ambrosio G; Belziti C; Lucas L; Arias A; D'Antonio A; Oberti P; Carluccio E; Pizarro R
Int J Cardiol; 2020 Oct; 317():111-120. PubMed ID: 32380249
[TBL] [Abstract][Full Text] [Related]
26. Effective blood hemoglobin level to predict prognosis in heart failure with preserved left ventricular ejection fraction: results of the Japanese heart failure syndrome with preserved ejection fraction registry.
Okuno K; Naito Y; Asakura M; Sugahara M; Ando T; Yasumura S; Nagai T; Saito Y; Yoshikawa T; Masuyama T; Anzai T
Heart Vessels; 2019 Jul; 34(7):1168-1177. PubMed ID: 30675647
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Significance of Serum Cholinesterase Level in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-HFpEF Registry.
Seo M; Yamada T; Tamaki S; Hikoso S; Yasumura Y; Higuchi Y; Nakagawa Y; Uematsu M; Abe H; Fuji H; Mano T; Nakatani D; Fukunami M; Sakata Y
J Am Heart Assoc; 2020 Jan; 9(1):e014100. PubMed ID: 31847660
[TBL] [Abstract][Full Text] [Related]
28. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
[TBL] [Abstract][Full Text] [Related]
30. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization.
Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171
[TBL] [Abstract][Full Text] [Related]
31. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2021 Jan; 37(1):255-266. PubMed ID: 32737707
[TBL] [Abstract][Full Text] [Related]
34. Low-density lipoprotein cholesterol, erythrocyte, and platelet in heart failure with preserved ejection fraction.
Yano M; Nishino M; Kawanami S; Ukita K; Kawamura A; Yasumoto K; Tsuda M; Okamoto N; Matsunaga-Lee Y; Egami Y; Yamada T; Yasumura Y; Seo M; Hayashi T; Nakagawa A; Nakagawa Y; Tamaki S; Sotomi Y; Nakatani D; Hikoso S; Sakata Y;
ESC Heart Fail; 2024 Jun; 11(3):1758-1766. PubMed ID: 38454876
[TBL] [Abstract][Full Text] [Related]
35. Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease).
Mentz RJ; Broderick S; Shaw LK; Fiuzat M; O'Connor CM
J Am Coll Cardiol; 2014 Jan; 63(3):251-8. PubMed ID: 24161322
[TBL] [Abstract][Full Text] [Related]
36. Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2020 May; 36(5):921-928. PubMed ID: 32030576
[TBL] [Abstract][Full Text] [Related]
37. Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
Pandey A; Golwala H; Sheng S; DeVore AD; Hernandez AF; Bhatt DL; Heidenreich PA; Yancy CW; de Lemos JA; Fonarow GC
JAMA Cardiol; 2017 Feb; 2(2):136-145. PubMed ID: 28030747
[TBL] [Abstract][Full Text] [Related]
38. Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy.
Liu J; Wang D; Ruan J; Wu G; Xu L; Jiang W; Wang J; Sun X; Kang L; Song L
BMC Med; 2022 Jan; 20(1):21. PubMed ID: 35078475
[TBL] [Abstract][Full Text] [Related]
39. [Predictive value of N-terminal B-type natriuretic peptide on outcome of elderly hospitalized non-heart failure patients].
Li YY; Liang YD; Yao SM; Zheng PP; Zeng XZ; Cui LL; Guo D; Wang H; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):661-668. PubMed ID: 32847322
[No Abstract] [Full Text] [Related]
40. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
